Jamesy Raffone of Manalapan is defying the experts, learning to drive despite Duchenne muscular dystrophy. The man least ...

Learn more Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at up to $2.65bn. The value includes a $1.55bn upfront payment and as much as ...

A charity event has raised more than £16,000 to fund research and support for people living with muscle-wasting conditions.

For Duchenne and Becker muscular dystrophies, muscle biopsy may show whether dystrophin, a muscle protein, is missing or abnormal, and DNA testing is used to analyze the condition of the related gene.

The muscular dystrophies represent disorders of progressive muscular degeneration and weakness. As a group, they exhibit clinical heterogeneity that reflects diverse molecular mechanisms responsible ...

Michael Sim helped his son, Aaron, see beyond his physical condition. Read more at straitstimes.com. Read more at straitstimes.com.

The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA) in patients with Duchenne muscular ...

Under the agreement, Servier will pay $1.55 billion upfront, with up to an additional $1.1 billion tied to regulatory and commercial milestones.

Edgewise Therapeutics on Monday agreed to sell its muscular dystrophy drug and related business to Servier in a deal worth up to $2.65 billion, marking an expansion for the French group beyond its ...

It was shortlisted for an Oscar and has received rave reviews.

Atlantic at Acadia University, representatives from Muscular Dystrophy Canada's Nova Scotia branch were on hand fu ...

Muscular dystrophy (MD) is a group of genetic diseases that cause your muscles to progressively weaken and degenerate. There are several types of MD, each with its own symptoms, but they all involve ...